Matthew Olsen

Dr. Matthew Olsen

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2024 in Journal of Exposure Science & Environmental Epidemiology
Verified
Journal Article
Open access
PDF file
LOLiam O’cAllaghan
Liam O’cAllaghan
MOMatthew Olsen
Matthew Olsen
LTLotti William Tajouri
Lotti William Tajouri
DBDavinia Beaver
Davinia Beaver
CHCarly Hudson
Carly Hudson
AGAdrian Goldsworthy
Adrian Goldsworthy
Introduction: In 2019 the World Health Organisation published a report which concluded microplastics in drinking water did not present a threat to human health. Since this time a plethora of research has emerged demonstrating the presence of plastic in various organ systems and their deleterious pathophysiological effects. Methods: A scoping review was undertaken in line with recommendations from the Johanna Briggs Institute. Five databases (PubMed, SCOPUS, CINAHL, Web of Science and EMBASE) were systematically searched in addition to a further grey literature search. Results: Eighteen articles were identified, six of which investigated and characterised the presence of microplastics and nanoplastics (MNPs) in the human urinary tract. Microplastics were found to be present in kidney, urine and bladder cancer samples. Twelve articles investigated the effect of MNPs on human cell lines associated with the human urinary tract. These articles suggest MNPs have a cytotoxic effect, increase inflammation, decrease cell viability and alter mitogen-activated protein kinases (MAPK) signalling pathways. Conclusion: Given the reported presence MNPs in human tissues and organs, these plastics may have potential health implications in bladder disease and dysfunction. As a result, institutions such as the World Health Organisation need to urgently re-evaluate their position on the threat of microplastics to public health. Impact statement: This scoping review highlights the rapidly emerging threat of microplastic contamination within the human urinary tract, challenging the World Health Organisation’s assertion that microplastics pose no risk to public health. The documented cytotoxic effects of microplastics, alongside their ability to induce inflammation, reduce cell viability and disrupt signalling pathways, raise significant public health concerns relating to bladder cancer, chronic kidney disease, chronic urinary tract infections and incontinence. As a result, this study emphasises the pressing need for further research and policy development to address the challenges surrounding microplastic contamination.

1 April 2025 in Journal of Exposure Science & Environmental Epidemiology
Verified
Journal Article
Open access
AGAdrian Goldsworthy
Adrian Goldsworthy
LOLiam A. O'Callaghan
Liam A. O'Callaghan
CBCiara Blum
Ciara Blum
Jarod HorobinJarod Horobin
Jarod Horobin
LTLotti William Tajouri
Lotti William Tajouri
John Francis FraserJohn Francis Fraser
John Francis Fraser
Background: The human bioaccumulation of micro- and nano-plastics (MNPs) is increasingly being recognised in the aetiology and pathophysiology of human disease. Objective: This systematic scoping review aims to provide a comprehensive investigation of studies examining the impacts of MNPs on the human cardiovascular system. Methods: Five databases (PubMed, SCOPUS, CINAHL, Web of Science and EMBASE) were systematically searched. Results: Forty-six articles were identified, 13 of which investigated the presence of MNPs within the human cardiovascular system, including atherosclerotic plaques, saphenous vein tissue, thrombi and venous blood. The effect of MNPs on cell lines suggest MNPs are cytotoxic, immunotoxic, and genotoxic. Significance: The findings of this review, when evaluated together with additional studies utilising animal models, suggest MNPs may contribute to global cardiovascular morbidity and mortality. In particular, the ability of MNPs to induce endothelial damage, oxy-LDL formation, foam cell development and apoptosis, as well as to alter the clotting cascade, has potential implications for vascular diseases. In addition, MNPs may play a role in the aetiology and progression of congenital heart abnormalities, infective pathologies and cardiomyopathies. Despite an increasing awareness of the ability for MNPs to result in cardiovascular disease and dysfunction, a limited amount of research has been conducted to date characterising the presence of MNPs in the human cardiovascular system. Reseach is required to understand the extent of this rapidly emerging issue and to develop strategies that will support clinicians to appropriately manage and educate their patients in the future.

17 April 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
AGAdrian Goldsworthy
Adrian Goldsworthy
MOMatthew Olsen
Matthew Olsen
AKAndy Hsien Wei Koh
Andy Hsien Wei Koh
TDThibaut Demaneuf
Thibaut Demaneuf
GSGobind Deep Singh
Gobind Deep Singh
LTLotti William Tajouri
Lotti William Tajouri
Extended reality (XR) devices, including virtual and augmented reality head-mounted displays (HMDs), are increasingly utilised within healthcare to provide clinical interventions and education. Currently, XR devices are utilised to assist in reducing pain and improving psychological outcomes for immunocompromised patients in intensive care units, palliative care environments and surgical theatres. However, there is a paucity of research on the risks of infection from such devices in healthcare settings. Identify existing literature providing insights into the infection control risk XR HMDs pose within healthcare facilities and the efficacy of current infection control and cleaning procedures. Three databases (PubMed, Embase and CINAHL) in addition to Google Scholar were systematically searched. A total of seven studies were identified for this review. Microorganisms, including pathogenic bacteria (e.g., Staphylococcus aureus and Pseudomonas aeruginosa), were found to be present on XR HMDs. Published cleaning and infection control protocols designed to disinfect XR HMDs and protect users were heterogeneous in nature. Current cleaning protocols displayed varying levels of efficacy with microbial load affected by multiple factors, including time in use, number of users and XR HMD design features. In healthcare settings, fitting XR HMDs harbouring microorganisms near biological and mucosal entry points presents an infection control risk. An urgent revision of the Spaulding classification is required to ensure flexibility that allows for these devices to be reclassified from ‘Non-critical’ to ‘Semi-Critical’ depending on the healthcare setting and patient population (surgery, immunocompromised, burns, etc.). This review identified evidence supporting the presence of microorganisms on XR HMDs. Due to the potential for HMDs to contact mucosal entry points, devices must be re-considered within the Spaulding classification as ‘Semi-critical’. The existence of microbial contaminated XR HMDs in high-risk medical settings such as operating wards, intensive care units, emergency departments, labour and delivery wards and clinical areas with immunosuppressed patients requires urgent attention. Public health authorities have a duty of care to develop revised guidelines or new recommendations to ensure efficient sanitation of such devices.

25 July 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
MOMatthew Olsen
Matthew Olsen
AGAdrian Goldsworthy
Adrian Goldsworthy
RNRania Nassar
Rania Nassar
ASAbiola Senok
Abiola Senok
AAAbdulla Albastaki
Abdulla Albastaki
SMSimon McKirdy
Simon McKirdy
Introduction. Mobile phones act as fomites that pose a global public health risk of disseminating microorganisms, including highly pathogenic strains possessing antimicrobial resistances. The use of ultraviolet-C (UV-C) to sanitise mobile phones presents an alternative means to complement basic hand hygiene to prevent the cross-contamination and dissemination of microorganisms between hands and mobile phones. Aim. This study aimed to evaluate the germicidal efficacy of the Glissner CleanPhone UV-C phone sanitiser (Glissner) device. Methods. Two experimental trials were performed for the evaluation of the CleanPhone (Glissner). The first was a controlled trial, where the germicidal efficacy of the CleanPhone was evaluated against six different microorganism species that were inoculated onto mobile phones. The second was a field trial evaluating the germicidal efficacy of the CleanPhone on 100 volunteer mobile phones. Efficacy was determined based on colony counts of microorganisms on Columbia sheep blood agar before and after UV-C treatment. Results. In the controlled trial, reduction in growth was observed for all microorganisms after UV-C treatment with ST131 Escherichia coli showing the highest growth reduction at 4 log10 CFU/mL followed by C. albicans and ATCC E. coli at 3 log10 CFU/mL. An overall reduction in microorganism growth after UV-C treatment was also observed for the field trial, with an average growth reduction of 84.4% and 93.6% in colony counts at 24 h and 48 h post-incubation, respectively. Conclusion. The findings demonstrated the capability of the CleanPhone (Glissner) to rapidly sanitise mobile phones, thereby providing a means to reduce the potential dissemination of microorganisms, including highly pathogenic strains with antimicrobial resistance.

23 October 2025 in Microplastics
Verified
Journal Article
Open access
PDF file
AGAdrian Goldsworthy
Adrian Goldsworthy
LOLiam A. O'Callaghan
Liam A. O'Callaghan
OTOystein Tronstad
Oystein Tronstad
JSJacky Suen
Jacky Suen
HCHonglin Chen
Honglin Chen
JFJohn Francis Fraser
John Francis Fraser
Background: Human bioaccumulation of micro- and nanoplastics (MNPs) is increasingly being recognised in the aetiology and pathophysiology of human disease. This systematic scoping review aims to provide a comprehensive investigation of studies examining the presence and effects of MNPs on the human pulmonary system. Methods: A scoping review was conducted in line with JBI guidelines. Five databases (PubMed, SCOPUS, CINAHL, Web of Science and EMBASE) were systematically searched. Results: Sixty-eight articles were identified, with fifteen reporting the presence of MNPs in human respiratory tissues and fluids. The data reported in the remaining toxicology-focused studies suggest that MNPs induce widespread cellular dysfunction in pulmonary-related human cell lines. Exposure to MNPs was associated with significant cytotoxicity, genotoxicity and altered metabolic activity, including mitochondrial damage, increased reactive oxygen species and reduced membrane potential. Functionalised and smaller particles had more pronounced effects. Conclusions: The reported presence of MNPs, coupled with their biological toxicity, represents a growing global health concern. Evidence suggests MNPs may contribute to the rising burden of pulmonary disease worldwide, including cancer, COPD, interstitial lung disease and ARDS. Urgent international research is needed to characterise exposure pathways, develop standardised detection methods and understand the long-term health implications of MNP inhalation across the lifespan.

10 April 2025 in Australian Critical Care
Verified
Journal Article
Open access
AGAdrian Goldsworthy
Adrian Goldsworthy
MSMohd Fairuz Shiratuddin
Mohd Fairuz Shiratuddin
OTOystein Tronstad
Oystein Tronstad
JFJohn F. Fraser
John F. Fraser
MOMatthew Olsen
Matthew Olsen
KWKok Wai Wong
Kok Wai Wong
The objective of this research was to investigate if the use of virtual reality, increasingly utilised within intensive care medicine due to its demonstrated benefits in improving pain and anxiety, has been reported to result in seizures. A rapid systematic review and synthesis of qualitative and quantitative data was performed. Five databases (PubMed, Scopus, EMBASE, PsycInfo, and CINAHL) were systematically searched. An additional gray literature search was also conducted. Articles were restricted to those published on or after January 1st, 2014. The number of participants, virtual reality sessions, and length of sessions was undertaken. Subgroup analysis was undertaken for both adult and paediatric patient populations. An additional subgroup analysis was undertaken on articles which did not exclude individuals with a history of epilepsy. A tailored risk-of-bias assessment was conducted. Of the 563 articles identified through database and gray literature searching, 27 articles met inclusion criteria. A total of 886 patients have been reported within the literature with a combined 1843 virtual reality sessions, totalling more than 614.64 h of virtual reality. No seizures have been reported within intensive care patients receiving virtual reality interventions. Historically, individuals with a history of epilepsy and photosensitivity have been commonly excluded from interventions and clinical trials involving virtual reality. The results of this systematic review demonstrate that the risk of virtual reality is minimal when utilised appropriately. A history of photosensitivity or epilepsy should not constitute an absolute contraindication for the use of virtual reality. Instead, clinicians should utilise clinical judgement when evaluating a patient's risk and ensure that appropriate visual experiences are utilised which do not unnecessarily strobe the patient.